Tag: Vaccine Market

Industry Focus Areas, Medical

Pfizer Squares Off With Merck on Pneumonia Shots

October 31, 2022

Via: The Wall Street Journal

Rival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor […]